Role of ergot derivatives in the treatment of parkinsonism.
D000097:Acetonitriles / Q000009:adverse effects / Q000627:therapeutic use; D000818:Animals; D001971:Bromocriptine / Q000627:therapeutic use; D004195:Disease Models, Animal; D004873:Ergolines / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D008099:Liver / Q000187:drug effects; D010300:Parkinson Disease / Q000188:drug therapy*; D011725:Pyridines / Q000009:adverse effects / Q000627:therapeutic use; D013329:Structure-Activity Relationship
D000097:Acetonitriles; D004873:Ergolines; D011725:Pyridines; D001971:Bromocriptine